ASIC2 and glioma: Inhibition of ASIC2 channels by recombinant analogs of Manbalkin-1 can control the carcinogenic process of leukemia (Bychkov M. L. et al., 2020), glioma (Bychkov M. et al., 2020) and melanoma (Bychkov et al., 2021) cells.